Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Using the Anovo Surgical System for ventral hernia repair

Official title: Clinical Assessment Protocol: Anovo Surgical System in Ventral Hernia

Run by Momentis Surgical · NCT06457971 · Data updated 2026-11-12

This study is testing a new robotic system for repairing ventral hernias to see if it is safe and effective for adults who need this surgery.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment50 (estimated)
SponsorMomentis Surgical
Industry-sponsored
Locations2 sites (Bonheiden and 1 other locations)
StatusRecruiting
StartedJanuary 14, 2024
Main results expectedDecember 2025
Study endsDecember 2025
Registry record updatedNovember 21, 2024
Trial IDNCT06457971 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older with ventral hernias who are suitable for robotic surgery.

Probably not a fit

Patients who are pregnant, breastfeeding, or have medical conditions that disqualify them from robotic surgery may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial assesses the Anovo Surgical System's effectiveness and safety in performing robotic ventral hernia repairs. Participants will undergo the procedure after extensive preclinical testing has confirmed the system's integrity. Eligible candidates include adults with ventral hernias who meet specific health criteria and can provide informed consent. The study aims to gather clinical data to support the system's use in surgical settings.

Why it matters

Potential benefit: If successful, this could lead to improved surgical outcomes and recovery for patients with ventral hernias.

How similar studies have gone: Other studies have shown promise in robotic surgical approaches for hernia repair, suggesting potential for success with this novel system.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Subject is at least 18 years old.
* Subjects able to provide written informed consent.
* Subject deemed eligible candidate by surgeon and will comply with the study procedures.
* Subjects with ventral hernia.
* Subjects with ASA grade I to III.
* Subject must sign and date informed consent prior to treatment.
* Subject can undergo general anesthesia per anesthesiologist assessment.

Exclusion Criteria:

* Women who are pregnant or breast-feeding or who wish to become pregnant during the period of the clinical investigation.
* Subject has medical condition, which in the judgement of the investigator makes the subject a poor candidate for the investigational procedure.
* Participation in another clinical trial that is in the active phase.
* Subject unwilling or inability to follow procedures outlined in the protocol.
* Subjects who are not suitable for robotic surgery, the Subject will be excluded from the study and the will be considered a screen failure and the surgeon will proceed with a standard multiport laparoscopic Hernia repair.
* Subjects who present any adverse event before use the Anovo Surgical System ("Anovo") that can affect evaluation of safety and performance of Investigational Device.

Where it's running

  • Imelda Hospital
    Bonheiden, Belgium
    Recruiting
  • Hadassah Medical Center
    Jerusalem, Israel
    Completed

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.